» Articles » PMID: 10573147

Protection and Antibody Responses in Different Strains of Mouse Immunized with Plasmid DNAs Encoding Influenza Virus Haemagglutinin, Neuraminidase and Nucleoprotein

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1999 Nov 26
PMID 10573147
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Protection against influenza virus infection and antibody responses in mice vaccinated with plasmid DNAs encoding haemagglutinin (HA), neuraminidase (NA) and nucleoprotein (NP) were compared among BALB/c (H-2d), B10 (H-2b) and C3H (H-2k) mice. Mice were inoculated with each DNA construct twice, 3 weeks apart, at a dose of 1 microg per mouse by particle-mediated DNA transfer (gene gun) to the epidermis. They were challenged with a lethal dose of the homologous virus 7 days after the second vaccination. NA-DNA provided significant protection in all strains of mouse, whereas HA-DNA afforded significant protection only in BALB/c mice. The serum antibody titres against NA or HA molecules in BALB/c, C3H and B10 mice were high, intermediate and low, respectively. NP-DNA failed to provide protection in any strain of mouse, and elicited low titres of anti-NP antibodies. These results suggest that NA-DNA can be used as a vaccine component to provide effective protection against influenza virus infection in various strains of mouse.

Citing Articles

Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice.

Bhatnagar N, Kim K, Subbiah J, Park B, Ko E, Seong B Antiviral Res. 2021; 197:105229.

PMID: 34933043 PMC: 8801234. DOI: 10.1016/j.antiviral.2021.105229.


Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection.

Xiong F, Liu X, Gao F, Luo J, Duan P, Tan W Emerg Microbes Infect. 2020; 9(1):78-87.

PMID: 31894728 PMC: 6968527. DOI: 10.1080/22221751.2019.1708214.


MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine.

Ko E, Lee Y, Lee Y, Kim Y, Kim K, Kang S Antiviral Res. 2018; 156:107-115.

PMID: 29885376 PMC: 6590071. DOI: 10.1016/j.antiviral.2018.06.004.


Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.

Kim Y, Lee Y, Kim M, Lee Y, Kim K, Ko E Front Immunol. 2017; 8:1730.

PMID: 29276514 PMC: 5727122. DOI: 10.3389/fimmu.2017.01730.


Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs.

Ricklin M, Python S, Vielle N, Brechbuhl D, Zumkehr B, Posthaus H Sci Rep. 2017; 7(1):16379.

PMID: 29180817 PMC: 5703990. DOI: 10.1038/s41598-017-16419-w.